XML 37 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Additional Information to the Items of Profit or Loss (Tables)
 6 Months Ended
Jun. 30, 2025
Additional Information to the Items of Profit or Loss [Abstract]  
Schedule of Additional Information to the Items of Profit or Loss
   Six months ended
June 30,		   Year Ended
December 31,		 
   2025   2024   2024 
   Unaudited   Audited 
   USD in thousands 
a. Research and development expenses:               
                
Wages and related expenses  $154   $224   $390 
Share-based payment   42    8    45 
Clinical studies   181    117    276 
Regulatory, professional and other expenses   390    386    681 
Research and preclinical studies   129    100    211 
Chemistry and formulations   42    6    104 
                
    938    841        1,707 
                
b. General and administrative expenses:               
                
Wages and related expenses   226    311    507 
Share-based payment   224    8    419 
Professional and directors’ fees   1,368    1,670    3,009 
Business development expenses   48    53    108 
Office maintenance, rent and other expenses   78    68    128 
Investor relations and business expenses   54    57    197 
Regulatory expenses   111    67    158 
                
   $2,109   $2,234    4,526